COLUMBUS,
Ohio – Dr. Clay Marsh (43221), a world-renowned and respected scientist and
educator at The Ohio State University
College of Medicine, recently received the Distinguished Alumnus Award
presented by the West Virginia University School of Medicine Alumni Association.
Marsh was honored for a lifetime of merit and outstanding accomplishments with
international or national recognition.
Marsh
received an undergraduate degree in biology in 1981 and earned his medical
degree from West Virginia University in 1985. He completed his residency in
internal medicine in 1988 at Ohio State, where he served as chief
resident.
The
prestigious award was established in 1984 to honor alumni “whose distinguished
careers and unselfish contributions to society have enhanced the prestige of
West Virginia University School of Medicine and, in their own way, have helped
to upgrade the quality of health care.” A candidate must be a graduate of the
West Virginia University School of Medicine whose career has been distinguished
by scholarly achievement, humanitarian contribution, or outstanding service to
the institution.
In 2009,
Marsh was appointed by The Ohio State University Board of Trustees as senior
associate vice president for research in the Office of Health Sciences, vice
dean for research in the
College of Medicine and executive director of the OSU Center for Personalized Health Care. Leading
The Ohio State University
Wexner Medical Center’s pioneering research program, Marsh is also guiding
the planning and expansion of the health system’s infinite research endeavors,
is responsible for recruitment of key researchers and heads the introduction of
advanced technology initiatives to Ohio State’s Wexner Medical
Center.
Under
Marsh’s executive leadership, Ohio State’s Center for Personalized Health Care
is earning international distinction through its leadership in a novel approach
to personalized health care known as P4 Medicine – predictive, preventive,
personalized and participatory medicine. P4 Medicine focuses on creating systems
to deliver health care focused on bringing the right intervention or treatment
to the right person at the right time to save money and improve outcomes. P4
Medicine enables the delivery of key evidence-based practices to reduce
healthcare costs and improve outcomes, and leverage the interface between an
individual’s unique DNA, environment and behavior to promote health and
wellness.
In addition,
P4 Medicine is focused on reducing the 17 year gap in “discovery to delivery” to
move innovations to users in a rapid timeframe. To accomplish this goal, OSU
Wexner Medical Center, has embedded entrepreneurs and companies in the P4
Medicine pipeline. Marsh has spearheaded the complementary positioning of
successful leaders and entrepreneurs in academia, industry and business, which
is key to delivering solutions to those who need them.
With Marsh
at the helm, Ohio State is a co-founder, along with the Institute for Systems
Biology, of the P4 Medicine Institute, a Seattle based non-profit innovation
consortium established in 2010 to lead the transformation of healthcare from a
reactive system to one that predicts and prevents disease, tailors diagnosis and
therapy to the individual consumer and engages patients in the active pursuit of
a quantified understanding of wellness. In addition, Ohio State recently
partnered with Allostatix and co-founded P44U, a neural network company focused
on creating prediction models and providing interventions to lower healthcare
costs.
Marsh, also
director of the Center for Critical Care and Respiratory Medicine at the Medical
Center, helped elevate the Division of Pulmonary, Allergy, Critical Care and
Sleep Medicine to a position of national prominence as its former
director.
Marsh has
won numerous teaching awards and has been recognized nationally for his research
and devotion to teaching and mentorship of medical students, residents and
fellows. He has been an invited speaker at various national conferences, has
published more than 130 journal articles and book chapters, and holds six U.S.
patent applications and 10 international patent
applications.
Marsh is a
member of several professional organizations including the American Thoracic
Society, the American College of Physicians, the American Federation for Medical
Research, the American Association for the Advancement of Science, the American
Association of Immunologists, the Federation of American Society for
Experimental Biology, the Central Society for Clinical Research, the American
Society for Biochemistry and Molecular Biology, the American Society for
Clinical Investigation, the Society for Critical Care Medicine, the Association
of Academic Health Centers, and the American College of
Physicians.
He also
serves on the board of the Personalized Medicine Coalition and has served as
chairman of the board of the Stanley Sarnoff Research Foundation, and as a
national leader in pulmonary medicine on the Battelle Bioinitiative in Pulmonary
Medicine.
###
Click here for a JPEG of
Dr. Clay Marsh, or go to: http://go.osu.edu/PC6
Contact:
Sherri Kirk, College of Medicine and Center for Personalized Health Care Public
Relations, 614.366.3277, or Sherri.Kirk@osumc.edu
